Evidence map›Paper›PMID 19945458›Full record

ArticleFEBS letters2010

Sialic acids acquired by Pseudomonas aeruginosa are involved in reduced complement deposition and siglec mediated host-cell recognition.

Biswajit Khatua, Angana Ghoshal, Kaushik Bhattacharya, Chandan Mandal, Bibhuti Saha, Paul R Crocker, Chitra Mandal

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in FEBS letters, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Immune response modulation bybioRxiv : the preprint server for biology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Sialic Acid-Siglec-E Interactions DuringFrontiers in immunology · 2020
    Article
  17. Siglecs at the Host-Pathogen Interface.Advances in experimental medicine and biology · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Biswajit KhatuaInfectious Diseases and Immunology Division, Indian Institute of Chemical Biology, Kolkata, India.
Angana Ghoshal
Kaushik Bhattacharya
Chandan Mandal
Bibhuti Saha
Paul R Crocker
Chitra Mandal
Indian Institute of Chemical Biology · INUniversity of Dundee · GB

Funding

Wellcome Trust 081882Wellcome Trust WT081882MA
6 · The paper itself

Abstract

The opportunism of Pseudomonas aeruginosa (PA) in immunocompromised hosts prompted us to explore the potential role of sialic acids (Sia) in this phenomenon. Culture of PA in the presence of exogenous Sia resulted in linkage-specific incorporation of Sia which was associated with decreased complement deposition on the bacteria. Sia acquired by PA mediated enhanced binding of bacteria to recombinant-CHO cells expressing human siglec-7 or siglec-9, as well as to human NK-cells and monocytes naturally expressing these siglecs. Therefore, Sia may be acquired by PA in the host and contribute to bacterial pathogenicity and host-cell interactions via reduction of complement deposition and siglec-dependent recognition.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticBacterial AdhesionCHO CellsCricetinaeCricetulusHumansLectinsPseudomonas aeruginosaSialic Acid Binding Immunoglobulin-like LectinsSialic AcidsAntigens, CDAntigens, Differentiation, MyelomonocyticLectinsSialic Acid Binding Immunoglobulin-like LectinsSialic AcidsSIGLEC7 protein, humanSIGLEC9 protein, human

Identifiers

PMID19945458
PMCPMC3640159
OpenAlexW2146547195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.